Maxwell et al
Machine learning-guided optimization of triple agonist peptide therapeutics for metabolic disease

Other episodes in this series The Pharmacists Voice Podcast Episode 328, Pronunciation Series Episode 54 (nalmefene) The Pharmacists Voice Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacists Voice Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacists Voice Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacists Voice Podcast episode 180, pronunciation series episode 9 Apretude (cabotegravir) The Pharmacists Voice Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC) The Pharmacists Voice Podcast episode 155, pronunciation series episode 5 Trulicity (dulaglutide) The Pharmacists Voice Podcast episode 148, pronunciation series episode 4 Besponsa (inotuzumab ozogamicin) The Pharmacists Voice Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacists Voice Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacists Voice Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta

You can store your Zepbound pens at room temperatureup to 86F (30C)for up to 21 days
Given the strong association between MASLD and cardiovascular pathology, that represents the primary cause of death in this population, the cardioprotective benefits of GLP-1 RAs provide important additional clinical value beyond hepatic benefits
Severe kidney disease or dehydration risk GI side effects can lead to dehydration and, in vulnerable patients, acute kidney injury